Invention Grant
- Patent Title: Pyridazinone compounds and their use as DAAO inhibitors
- Patent Title (中): 哒嗪酮化合物及其作为DAAO抑制剂的用途
-
Application No.: US14240045Application Date: 2012-08-21
-
Publication No.: US09290456B2Publication Date: 2016-03-22
- Inventor: William Farnaby , Charlotte Fieldhouse , Katherine Hazel , Catrina Kerr , Natasha Kinsella , David Livermore , Kevin Merchant , David Miller
- Applicant: William Farnaby , Charlotte Fieldhouse , Katherine Hazel , Catrina Kerr , Natasha Kinsella , David Livermore , Kevin Merchant , David Miller
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Priority: GB1114399.7 20110822; GB1118658.2 20111027; GB1203533.3 20120229
- International Application: PCT/GB2012/000672 WO 20120821
- International Announcement: WO2013/027000 WO 20130228
- Main IPC: C07D237/16
- IPC: C07D237/16 ; C07D401/06 ; A61K31/50 ; A61K31/501 ; C07D401/10 ; C07D407/10 ; A61K45/06 ; C07D237/18 ; C07D237/22 ; C07D405/06 ; C07F7/08
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Public/Granted literature
- US20150030704A1 PYRIDAZINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS Public/Granted day:2015-01-29
Information query
